Cite
Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA
MLA
Askling, J., et al. Risk of Tuberculosis in Rheumatoid Arthritis and Following Anti-TNF Treatment. Preliminary Results of an Ongoing Swedish Monitoring-Programme of Biologics in RA. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234218224&authtype=sso&custid=ns315887.
APA
Askling, J., Fored, C. M., Brandt, L., Baecklund, E., Bertilsson, L., Coster, L., Geborek, P., Jacobsson, L. T., Lindblad, S., Lysholm, J., Rantapää-Dahlqvist, S., Saxne, T., Romanus, V., Klareskog, L., & Feltelius, N. (2005). Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA.
Chicago
Askling, J, C M Fored, L Brandt, E Baecklund, L Bertilsson, L Coster, P Geborek, et al. 2005. “Risk of Tuberculosis in Rheumatoid Arthritis and Following Anti-TNF Treatment. Preliminary Results of an Ongoing Swedish Monitoring-Programme of Biologics in RA.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234218224&authtype=sso&custid=ns315887.